Friday 12th of April 2024

40 years on and Bob Champion embarks on Anniversary walk

40 years to the day since Bob Champion won his battle with cancer and the world’s most famous horse race, he is to set off on #Bobs40For40Challenge sponsored by the Wadsell Group, to raise more funds for The Bob Champion Cancer Trust.

Bob and Aldaniti

Leaving from the hallowed turf of Aintree on 11 April, the day after the Randox Grand National 2021, Bob will embark on a 191 mile route, which represents the 191 days from his diagnosis on 24th July 1979, his months of gruelling treatment to then receiving the all clear 31st January 1980 – and going on to win the Grand National the following year.

This 40th Anniversary walk will be unique in the fact that it will not be a linear route, but Bob will cover the 191 miles in 40 memorable stops, all connected to his remarkable life story and representing every year from 1981 – 2021.  It will finish at Findon, the place where Aldanti was trained and where the Gifford family carry on the family legacy.

The stops include trainer’s yards such as Tom Dascombe, Dan Skelton and Jonjo O’Neill (full list to be confirmed soon) and places of interest such as Barkfold Manor, where Aldaniti lived in retirement and is buried. At each place, Bob will walk up and down the gallops, or in a circuit, and well-known people will join him along the way. Members of the public can apply to get themselves sponsored to join him on certain days. All visits will be covid secure. To apply, please visit


In doing #Bobs40For40Challenge he aims to raise much needed funds for The Bob Champion Cancer Trust, which has to date raised in excess of £15 million towards cancer research. Bob says:

“My story 40 years ago gave hope to people around the world fighting cancer. I have dedicated my life to the cause and hope that people will support me again on this anniversary walk for the good work my Trust does on a daily basis.”

If you would like to support Bob, click the link here in aid of the Bob Champion Cancer Trust, which is focused in understanding the detailed molecular basis of the development of prostate cancer. Success of this research will ultimately lead to better clinical management of this cancer and to new cancer tests and treatments.

You may also like…

Join us on Facebook

Follow on Twitter